Vitiligo, autoimmune thyroiditis: A rare thyroid cancer arising with bone metastates on maxillofacial area

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 1, 1999, Pages 85-87

  Frati, R ^a   Frati, C ^b   Sassano, P P ^a   Antonaci, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Division of Dermatology   (Italy)

Author keywords

Autoimmunity; Thyroid cancer; Vitiligo

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; AUTOIMMUNE DISEASE; BONE METASTASIS; CONTROLLED STUDY; HASHIMOTO DISEASE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAXILLA; PRIORITY JOURNAL; THYROID CARCINOMA; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; ITALY; MALE; MAXILLARY NEOPLASMS; MIDDLE AGED; THYROID DISEASES; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VITILIGO;

EID: 0032932935     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Parkon C.I., Derevici M.: Sur l'association du syndrome de Basedow avec le vitiligo. Rev. Fr. Endocrinol., 7: 12, 1929.
2. Lerner A.B.: Vitiligo. J. Invest. Derm., 32: 285, 1959.
3. Hegedus L., Heidenheim M., Gervil M., Hjalgrim H., Hoier Madsen M.: High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm. Venereol., 74: 120-3, 1994.
4. Ochi Y., DeGroot L.J.: Vitiligo in Grave's disease. Ann. Intern. Med., 71: 935-40, 1969.
5. Pal S.K., Ghosh K.K., Banerjee P.K.: Thyroid function in vitiligo. Clin. Chim. Acta, 106: 331-2, 1980.
6. Muto M., Furumoto H., Ohmura A., Asagami C.: Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture. J Dermatol., 22: 770-2, 1995.
7. Cunliff W.J., Hall R., Newell D.J., Stevenson C.J.: Vitiligo, thyroid disease and autoimmunity. Br. J. Derm., 80: 135-9, 1968.
8. Brostoff J., Bor S., Feiwel M.: Autoantibodies in patients with vitiligo. Lancet, 1: 177, 1969.
9. Woolfson H., Finn O.A., Mackie R.M. et al.: Serum anti-tumour antibodies and autoantibodies in vitiligo. Br. J. Dermatol., 92: 395-400, 1969.
10. Frati C.: Fenomeni autoimmunitari in 301 vitiligoidei ed in 92 famigliari sani. Chron. Derm., 4: 513, 1979.
11. Grimes P.E., Halder R., Jones C. et al.: Autoantibodies and their clinical significance in black vitiligo populations. Arch. Dermatol., 119: 300-3, 1983.
12. Schallreuter K.U., Lemke R., Brandt O., Schwartz R., Westhofen M., Montz R., Berger J.: Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology, 188: 269-75, 1994.
13. Mandry R.C., Ortiz L.J., Lugo Somolinos A., Sanchez J.L.: Organ-specific autoantibodies in vitiligo patients and their relatives. Int. J. Dermatol., 35: 18-21, 1996.
14. Masala C., Frati C., Amendolea M.A.: Autoimmune gastritis in young patients with vitiligo and in their young relatives. Ital. Gentile Rev. of Dermat., 16: 141, 1979.
15. Frati C., Martone F.R., Amendolea M.A., Masala C.: Is organ-specific autoimmunity a risk for vitiligo ? J. EADV, 5: S/97, 1995.
16. Masala C., Amendolea M.A., Molliconi D., Frati C.: Autoimmunità e vitiligine. Atti XXX° Congresso ADOI, 79-85, 1996.
17. Weiss G.R., Fehrenkamp S.H., Tokaz L.K., Sunderland M.C.: Vitiligo and Graves' disease following treatment of malignant melanoma with recombinant human interleukin 4. Dermatology, 192: 283-5, 1996.